Antiobesity pharmacotherapy in the management of type 2 diabetes.
about
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitusPharmacotherapy for weight loss in adults with type 2 diabetes mellitusThe sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data.Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
P2860
Antiobesity pharmacotherapy in the management of type 2 diabetes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@ast
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@en
type
label
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@ast
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@en
prefLabel
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@ast
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@en
P2860
P1476
Antiobesity pharmacotherapy in the management of type 2 diabetes.
@en
P2093
Lefèbvre PJ
P2860
P304
P356
10.1002/(SICI)1520-7560(200003/04)16:2<114::AID-DMRR97>3.0.CO;2-O
P577
2000-03-01T00:00:00Z